Yoshiro Ishiwata
20Patents
5h-index
57Co-inventors
72Inventor score
Filing activity: Nov 2, 1982 → Jan 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4528184A | Polymer-metal complexes containing quaternary nitrogen atoms used in the treatment of hypercholesteremia | Chemistry; Metallurgy | 19 | Expired |
| US6962926B2 | Antagonist of MCP-1 function, and compositions and methods of use thereof | Human Necessities | 9 | Expired |
| US7297696B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 9 | Expired |
| US5356880A | Glycyrrhetinic acid derivatives | Chemistry; Metallurgy | 7 | Expired |
| US6670364B2 | Antagonists of MCP-1 function and methods of use thereof | Human Necessities | 6 | Expired |
| US6677365B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US5340806A | Composition containing organogermanium compound and immunity adjusting agent comprising the composition | Human Necessities | 3 | Expired |
| US6809113B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US5260056A | Composition for enhancing biosynthesis of interferon | Human Necessities | 2 | Expired |
| US5730971A | Potentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiator | Human Necessities | 2 | Expired |
| US5279835A | Binder-free orally administrable tablet containing 3-oxygermylpropionic acid | Human Necessities | 2 | Expired |
| US5336688A | Composition containing organogermanium compound and immunity adjusting agents comprising the compositions | Human Necessities | 2 | Expired |
| US11572393B2 | HMGN partial peptide and cancer therapy using the same | Human Necessities | 1 | Active |
| US5560925A | Method of treating wart | Chemistry; Metallurgy | 1 | Expired |
| US10746726B2 | Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient | Physics | 1 | Active |
| US11919932B2 | HMGN partial peptide and cancer therapy using the same | Human Necessities | 0 | Active |
| US5621003A | Maillard reaction inhibitor | Human Necessities | 0 | Expired |
| US6992086B2 | Antagonists of MCP-1 function and methods of use thereof | Human Necessities | 0 | Expired |
| US6998407B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US11168137B2 | Method for reducing side effects of immune checkpoint control agent | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.